Media Highlights
Jaypirca, ‘Much-Needed’ Treatment for CLL and SLL, Approved by FDA
December 13, 2023
Dr. Juan Alderuccio weighs in on the clinical benefits of the newly approved treatment (Japirca) for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
